GF
GPCR icon

Gabelli Funds’s Structure Therapeutics GPCR Stock Holding History

Gabelli Funds’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+4,050
New +$179K ﹤0.01% 1169
2026
Q1 		– Sell
-4,000
Closed -$278K – 1294
2025
Q4 		$278K Buy
+4,000
New +$163K ﹤0.01% 1123

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Gabelli Funds's GPCR Position: Q2 2026 in Review

Gabelli Funds opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 4,050 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1169 among its holdings. This is a return to the name: Gabelli Funds previously reported a position in GPCR as recently as Q4 2025.

Gabelli Funds first reported a position in GPCR in Q4 2025 and has held it in 2 quarters since. The position peaked at $278K in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Gabelli Funds held 4,050 shares of Structure Therapeutics worth $217K as of Q2 2026.
  • Structure Therapeutics was a new Gabelli Funds position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1169 holding.
  • Gabelli Funds first reported a position in Structure Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Gabelli Funds's Structure Therapeutics position peaked at $278K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.